Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 16Gastrointestinal 2Thoracic 1Other 1CNS 1

Conditions

Lung Neoplasms 4Thromboembolism 2Carcinoma, Non-Small-Cell Lung 2Venous Thrombosis 1Venous Thromboembolism 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Pulmonary Embolism 1Prostatic Neoplasms 1Hemorrhage 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

Tinzaparin 2Fondaparinux 2sotorasib 1Rivaroxaban 1Nadroparin 1Gemcitabine 1Drug Therapy 1Dalteparin 1ALT-836 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Venous Thromboembolism × Dalteparin × Thoracic × Clear all
NCT02334007 2018-09-18

Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery

McMaster University

Phase 1/2 Completed
102 enrolled
Classical hematologyThoracic

Lung Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡